Naquita Ahern, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 501 N Navajo Rd, Page, AZ 86040 Phone: 928-645-0155 |
Barbara Bananov, PT,DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 39 6th Ave # 3304, Page, AZ 86040 Phone: 212-444-2678 |
Dr. George Wertz, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 39 6th Ave, Page, AZ 86040 Phone: 928-645-5780 Fax: 928-433-4992 |
Theodore Martin Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 39 6th Avenue, Page, AZ 86040 Phone: 928-812-0152 |
News Archive
A study published in the New England Journal of Medicine on 20th July 2017 suggests that a cocktail of drugs, if provided at the beginning of the HIV therapy, can save over 10,000 lives per year. HIV, which is often diagnosed late, leaves people vulnerable to other diseases by ravaging the immune system.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
Amneal Pharmaceuticals, LLC is pleased to announce that its generic Felbamate tablets are now available in 400 mg and 600 mg strengths. Amneal's latest First-to-Market product is an AB-rated, therapeutically equivalent alternative to the antiepileptic drug Felbatol. Annual U.S. sales of Felbatol® are $43.7 million according to January 2011 IMS Health market data.
Administering heart resuscitation drugs to patients whose cardiac arrest is witnessed at the time of the attack can improve survival, but needs to be done through an IV line rather than directly into bone marrow as is more commonly done by paramedics, a new study involving UT Southwestern Medical Center emergency physicians and Dallas-Fort Worth Emergency Medical Services agencies reveals.
SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.
› Verified 9 days ago